Try Fund Library Premium
For Free with a 30 day trial!
Health Care Equity
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade.
|
Close (12-12-2025) |
$7.92 |
|---|---|
| Change |
$0.07
(0.82%)
|
| Open | $7.93 |
|---|---|
| Day Range | $7.91 - $7.93 |
| Volume | 3,945 |
As at November 30, 2025
As at May 31, 2025
As at November 30, 2025
Inception Return (September 24, 2015): 5.87%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 5.88% | 12.16% | 13.72% | 16.20% | 8.54% | 9.17% | 3.92% | 1.46% | 4.73% | 4.88% | 5.44% | 6.33% | 7.17% | 5.70% |
| Benchmark | 7.21% | 13.51% | 18.59% | 12.85% | 9.19% | 12.51% | 7.70% | 6.84% | 7.73% | 8.59% | 8.64% | 9.53% | 10.46% | 8.79% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 41 / 51 | 36 / 51 | 43 / 51 | 10 / 50 | 15 / 50 | 29 / 48 | 30 / 41 | 38 / 40 | 26 / 38 | 30 / 35 | 25 / 34 | 23 / 31 | 23 / 29 | 22 / 29 |
| Quartile Ranking | 4 | 3 | 4 | 1 | 2 | 3 | 3 | 4 | 3 | 4 | 3 | 3 | 4 | 4 |
| Return % | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -6.59% | 6.97% | 1.25% | -0.53% | -2.94% | -2.28% | 0.84% | -3.47% | 4.17% | 1.33% | 4.55% | 5.88% |
| Benchmark | -3.25% | 6.66% | 0.57% | -2.81% | -5.42% | -3.48% | 0.91% | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% |
10.62% (April 2020)
-11.20% (January 2022)
| Return % | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | -6.29% | 11.24% | 4.97% | 21.97% | 6.28% | 24.13% | -14.33% | -1.52% | -0.13% |
| Benchmark | 27.73% | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | 1 | 2 | 3 | 1 | 4 | 1 | 4 | 4 | 4 |
| Category Rank | - | 7/ 29 | 12/ 29 | 20/ 32 | 4/ 34 | 34/ 35 | 3/ 38 | 39/ 40 | 35/ 41 | 45/ 48 |
24.13% (2021)
-14.33% (2022)
| Name | Percent |
|---|---|
| US Equity | 78.08 |
| International Equity | 18.66 |
| Cash and Equivalents | 3.26 |
| Name | Percent |
|---|---|
| Healthcare | 83.00 |
| Consumer Services | 10.63 |
| Cash and Cash Equivalent | 3.26 |
| Consumer Goods | 3.11 |
| Name | Percent |
|---|---|
| North America | 81.34 |
| Europe | 18.65 |
| Other | 0.01 |
| Name | Percent |
|---|---|
| Cardinal Health Inc | 5.68 |
| McKesson Corp | 4.94 |
| Intuitive Surgical Inc | 4.72 |
| Boston Scientific Corp | 4.61 |
| Cigna Corp | 4.24 |
| Johnson & Johnson | 4.23 |
| Eli Lilly and Co | 4.15 |
| Sanofi SA - ADR | 4.14 |
| Amgen Inc | 4.09 |
| Gilead Sciences Inc | 4.08 |
Brompton Global Healthcare Income & Growth ETF - CAD Units
Median
Other - Health Care Equity
| Standard Deviation | 11.90% | 14.69% | 14.03% |
|---|---|---|---|
| Beta | 0.96% | 1.14% | 0.99% |
| Alpha | -0.03% | -0.04% | -0.03% |
| Rsquared | 0.74% | 0.77% | 0.70% |
| Sharpe | 0.05% | 0.20% | 0.34% |
| Sortino | 0.19% | 0.26% | 0.36% |
| Treynor | 0.01% | 0.03% | 0.05% |
| Tax Efficiency | 11.50% | 37.52% | - |
| Volatility |
|
|
|
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 14.32% | 11.90% | 14.69% | 14.03% |
| Beta | 0.91% | 0.96% | 1.14% | 0.99% |
| Alpha | 0.00% | -0.03% | -0.04% | -0.03% |
| Rsquared | 0.81% | 0.74% | 0.77% | 0.70% |
| Sharpe | 0.45% | 0.05% | 0.20% | 0.34% |
| Sortino | 0.70% | 0.19% | 0.26% | 0.36% |
| Treynor | 0.07% | 0.01% | 0.03% | 0.05% |
| Tax Efficiency | 58.85% | 11.50% | 37.52% | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | September 24, 2015 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Monthly |
| Assets ($mil) | - |
| 52 Week High | $8.30 |
| 52 Week Low | $7.06 |
| Annual Dividend | $0.66 |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | 1x performance |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | Yes |
The investment objectives of HIG are to provide HIG Unitholders with: (i) stable monthly cash distributions; (ii) the opportunity for capital appreciation; and (iii) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies directly. HIG seeks to hedge substantially all of its exposure to foreign currencies back to the Canadian dollar.
This ETF provides high monthly distributions and the opportunity for capital gains through an investment in a portfolio of large cap global Healthcare companies selected by Brompton, complemented by an actively managed covered call program. Our PM team first uses top-down analysis to identify attractive sub-sectors. Rigorous fundamental analysis focuses the portfolio on 15 to 30 global Healthcare companies which offer a combination of growth and value characteristics.
| Portfolio Manager |
Brompton Funds Limited
|
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
Brompton Funds Limited |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
| MER | 0.96% |
|---|---|
| Management Fee | 0.75% |
Try Fund Library Premium
For Free with a 30 day trial!